Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
Public ClinicalTrials.gov record NCT00413283. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2, Randomized, Double Blind, Placebo-Controlled Dose and Schedule Finding Trial to Evaluate the Safety and Efficacy of AMG 531 For Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Advanced Non-Small Cell Lung Cancer Already Receiving Gemcitabine and Platinum.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to identify an effective, well tolerated dose and schedule of romiplostim that is appropriate for the treatment of chemotherapy induced thrombocytopenia (CIT) in patients with non-small cell lung cancer receiving gemcitabine and platinum.
Study identification
- NCT ID
- NCT00413283
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 63 participants
Conditions and interventions
Conditions
Interventions
- Romiplostim Biological
- Placebo Drug
- Gemcitabine Drug
- Carboplatin Drug
- Cisplatin Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2006 (Type not available)
- Primary completion
- Dec 2008 (Actual)
- Completion
- Feb 2009 (Actual)
- Last update posted
- Oct 24, 2013
2006 – 2009
United States locations
- U.S. sites
- 51
- U.S. states
- 18
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Glendale | Arizona | 85304 | — |
| Research Site | Glendale | Arizona | — | — |
| Research Site | Anaheim | California | 92801 | — |
| Research Site | Anaheim | California | — | — |
| Research Site | Los Angeles | California | 90048 | — |
| Research Site | Los Angeles | California | — | — |
| Research Site | Rancho Mirage | California | 92270 | — |
| Research Site | Rancho Mirage | California | — | — |
| Research Site | Boynton Beach | Florida | 33435 | — |
| Research Site | Boynton Beach | Florida | — | — |
| Research Site | Vero Beach | Florida | 32960 | — |
| Research Site | Vero Beach | Florida | — | — |
| Research Site | Athens | Georgia | 30607 | — |
| Research Site | Athens | Georgia | — | — |
| Research Site | Macon | Georgia | 31201 | — |
| Research Site | Macon | Georgia | — | — |
| Research Site | Peoria | Illinois | 61615 | — |
| Research Site | Peoria | Illinois | — | — |
| Research Site | Sioux City | Iowa | 51101 | — |
| Research Site | Sioux City | Iowa | — | — |
| Research Site | Paducah | Kentucky | 42003 | — |
| Research Site | Paducah | Kentucky | — | — |
| Research Site | Shreveport | Louisiana | 71101 | — |
| Research Site | Shreveport | Louisiana | — | — |
| Research Site | Baltimore | Maryland | 21201 | — |
| Research Site | Baltimore | Maryland | — | — |
| Research Site | Sterling Heights | Michigan | 48314 | — |
| Research Site | Sterling Heights | Michigan | — | — |
| Research Site | Billings | Montana | 59101 | — |
| Research Site | Billings | Montana | — | — |
| Research Site | Flemington | New Jersey | 08822 | — |
| Research Site | Flemington | New Jersey | — | — |
| Research Site | Johnson City | New York | 13790 | — |
| Research Site | Johnson City | New York | — | — |
| Research Site | Oklahoma City | Oklahoma | 73104 | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Drexel Hill | Pennsylvania | 19026 | — |
| Research Site | Drexel Hill | Pennsylvania | — | — |
| Research Site | Dunmore | Pennsylvania | 18512 | — |
| Research Site | Dunmore | Pennsylvania | — | — |
| Research Site | Radnor | Pennsylvania | 19087 | — |
| Research Site | Radnor | Pennsylvania | — | — |
| Research Site | Columbia | South Carolina | 29203 | — |
| Research Site | Columbia | South Carolina | — | — |
| Research Site | Germantown | Tennessee | 38138 | — |
| Research Site | Germantown | Tennessee | — | — |
| Research Site | Austin | Texas | 78705 | — |
| Research Site | Austin | Texas | — | — |
| Research Site | Houston | Texas | 77030 | — |
| Research Site | Houston | Texas | 77074 | — |
| Research Site | Houston | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00413283, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 24, 2013 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00413283 live on ClinicalTrials.gov.